A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

Nature Microbiology

Volumn 2, Issue , 2017, Pages

  Mousa, Jarrod J ^a   Kose, Nurgun ^a   Matta, Pranathi ^a   Gilchuk, Pavlo ^a   Crowe, James E ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; F PROTEIN, HUMAN RESPIRATORY SYNCYTIAL VIRUS; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; PROTEIN BINDING; VIRUS ANTIBODY; VIRUS FUSION PROTEIN;

CHEMISTRY; CROSS REACTION; EPITOPE MAPPING; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR MODEL; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CROSS REACTIONS; CRYSTALLOGRAPHY, X-RAY; EPITOPE MAPPING; EPITOPES; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; VIRAL FUSION PROTEINS;

EID: 85011309150     PISSN: None     EISSN: 20585276     Source Type: Journal    
DOI: 10.1038/nmicrobiol.2016.271     Document Type: Article

References (22)

1. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102, 531-537 (1998).
2. Smith, E. C., Popa, A., Chang, A., Masante, C. & Dutch, R. E. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J. 276, 7217-7227 (2009).
3. McLellan, J. S., Yang, Y., Graham, B. S. & Kwong, P. D. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J. Virol. 85, 7788-7796 (2011).
4. McLellan, J. S. et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340, 1113-1117 (2013).
5. McLellan, J. S. et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science 342, 592-598 (2013).
6. Krarup, A. et al. A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism. Nat. Commun. 6, 8143 (2015).
7. Anderson, L. J. et al. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J. Infect. Dis. 151, 626-633 (1985).
8. Wu, H. et al. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J. Mol. Biol. 368, 652-665 (2007).
9. Wu, S. J. et al. Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches. J. Gen. Virol. 88, 2719-2723 (2007).
10. Lopez, J. A. et al. Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J. Virol. 72, 6922-6928 (1998).
11. Gilman, M. S. A. et al. Characterization of a prefusion-specific antibody that recognizes a quaternary, cleavage-dependent epitope on the RSV fusion glycoprotein. PLoS Pathogens 11, e1005035 (2015).
12. Corti, D. et al. Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. Nature 501, 439-443 (2013).
13. McLellan, J. S. Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein. Curr. Opin. Virol. 11, 70-75 (2015).
14. Mousa, J. J. et al. Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein. Proc. Natl Acad. Sci. USA 113, E6849-E6858 (2016).
15. Ngwuta, J. O. et al. Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera. Sci. Transl. Med. 7, 309ra162 (2015).
16. Smith, S. A. & Crowe, J. E. Use of human hybridoma technology to isolate human monoclonal antibodies. Microbiol. Spectr. 3, 1-12 (2015).
17. Strong, M. et al. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 103, 8060-8065 (2006).
18. Brochet, X., Lefranc, M. P. & Giudicelli, V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 36, 503-508 (2008).
19. Yu, X., McGraw, P. A., House, F. S. & Crowe, J. E. An optimized electrofusionbased protocol for generating virus-specific human monoclonal antibodies. J. Immunol. Methods 336, 142-151 (2008).
20. Kabsch, W. XDS. Acta Crystallogr. 66, 125-132 (2010).
21. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. 66, 213-221 (2010).
22. Emsley, P. & Cowtan, K. COOT: model-building tools for molecular graphics. Acta Crystallogr. 60, 2126-2132 (2004).